B-RAF is a therapeutic target in melanoma
Top Cited Papers
- 21 June 2004
- journal article
- Published by Springer Nature in Oncogene
- Vol. 23 (37) , 6292-6298
- https://doi.org/10.1038/sj.onc.1207785
Abstract
B-RAF is a serine/threonine-specific protein kinase that is mutated in approximately 70% of human melanomas. However, the role of this signalling molecule in cancer is unclear. Here, we show that ERK is constitutively activated in melanoma cells expressing oncogenic B-RAF and that this activity is required for proliferation. B-RAF depletion by siRNA blocks ERK activity, whereas A-RAF and C-RAF depletion do not affect ERK signalling. B-RAF depletion inhibits DNA synthesis and induces apoptosis in three melanoma cell lines and we show that the RAF inhibitor BAY43-9006 also blocks ERK activity, inhibits DNA synthesis and induces cell death in these cells. BAY43-9006 targets B-RAF signalling in vivo and induces a substantial growth delay in melanoma tumour xenografts. Our data demonstrate that oncogenic B-RAF activates ERK signalling, induces proliferation and protects cells from apoptosis, demonstrating that it is an important therapeutic target and thus provides novel strategies for clinical management of melanoma and other cancers.Keywords
This publication has 20 references indexed in Scilit:
- Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAFPublished by Elsevier ,2004
- Role of Raf in Vascular Protection from Distinct Apoptotic StimuliScience, 2003
- Mutations in BRAF and KRAS Characterize the Development of Low-Grade Ovarian Serous CarcinomaJNCI Journal of the National Cancer Institute, 2003
- RAF/RAS oncogenes and mismatch-repair statusNature, 2002
- Mutations of the BRAF gene in human cancerNature, 2002
- S338 Phosphorylation of Raf-1 Is Independent of Phosphatidylinositol 3-Kinase and Pak3Molecular and Cellular Biology, 2001
- Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemiaJournal of Clinical Investigation, 2000
- Abrogation of c-Raf expression induces apoptosis in tumor cellsOncogene, 1998
- Endothelial apoptosis in Braf-deficient miceNature Genetics, 1997
- Differential Regulation of Raf-1, A-Raf, and B-Raf by Oncogenic Ras and Tyrosine KinasesJournal of Biological Chemistry, 1997